Koert Gerzon

1.9k total citations
42 papers, 1.5k citations indexed

About

Koert Gerzon is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Koert Gerzon has authored 42 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Organic Chemistry and 5 papers in Pharmacology. Recurrent topics in Koert Gerzon's work include Ion channel regulation and function (6 papers), Biochemical and Molecular Research (5 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). Koert Gerzon is often cited by papers focused on Ion channel regulation and function (6 papers), Biochemical and Molecular Research (5 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). Koert Gerzon collaborates with scholars based in United States, Canada and Germany. Koert Gerzon's co-authors include Paul F. Wiley, Max V. Sigal, Edwin H. Flynn, Donald C. DeLong, Martin Sweeney, Gerald A. Poore, George J. Cullinan, Mary A. Root, J. C. Cline and Frederick J. Marshall and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

Koert Gerzon

41 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Koert Gerzon United States 24 775 546 246 133 128 42 1.5k
Paul F. Wiley United States 24 838 1.1× 743 1.4× 543 2.2× 169 1.3× 67 0.5× 70 1.7k
Walter E. DeWolf United States 26 984 1.3× 620 1.1× 147 0.6× 163 1.2× 119 0.9× 50 1.9k
W. Rittel Switzerland 29 1.6k 2.1× 739 1.4× 83 0.3× 206 1.5× 154 1.2× 66 2.4k
George Y. Lesher United States 15 562 0.7× 606 1.1× 349 1.4× 86 0.6× 100 0.8× 45 1.4k
Thomas J. Perun United States 20 678 0.9× 612 1.1× 222 0.9× 65 0.5× 69 0.5× 48 1.4k
Ralph T. Mosley United States 25 814 1.1× 562 1.0× 166 0.7× 100 0.8× 232 1.8× 43 1.7k
Wallace T. Ashton United States 22 767 1.0× 588 1.1× 67 0.3× 166 1.2× 226 1.8× 59 1.8k
Tsutomu Irikura Japan 15 753 1.0× 332 0.6× 712 2.9× 153 1.2× 138 1.1× 67 1.6k
V. P. MARSHALL United States 20 695 0.9× 232 0.4× 224 0.9× 194 1.5× 33 0.3× 56 1.2k
Fabio Sparatore Italy 26 846 1.1× 1.6k 2.9× 232 0.9× 401 3.0× 98 0.8× 137 2.4k

Countries citing papers authored by Koert Gerzon

Since Specialization
Citations

This map shows the geographic impact of Koert Gerzon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koert Gerzon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koert Gerzon more than expected).

Fields of papers citing papers by Koert Gerzon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koert Gerzon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koert Gerzon. The network helps show where Koert Gerzon may publish in the future.

Co-authorship network of co-authors of Koert Gerzon

This figure shows the co-authorship network connecting the top 25 collaborators of Koert Gerzon. A scholar is included among the top collaborators of Koert Gerzon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koert Gerzon. Koert Gerzon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tinker, Andrew, John L. Sutko, Luc Ruest, et al.. (1996). Electrophysiological effects of ryanodine derivatives on the sheep cardiac sarcoplasmic reticulum calcium-release channel. Biophysical Journal. 70(5). 2110–2119. 43 indexed citations
2.
Bidasee, Keshore R., Henry R. Besch, Koert Gerzon, & Rod Humerickhouse. (1995). Activation and deactivation of sarcoplasmic reticulum calcium release channels: Molecular dissection of mechanisms via novel semi-synthetic ryanoids. Molecular and Cellular Biochemistry. 149-150(1). 145–160. 9 indexed citations
3.
Welch, William H., Syed Sayeed Ahmad, Judith A. Airey, et al.. (1994). Structural Determinants of High-Affinity Binding of Ryanoids to the Vertebrate Skeletal Muscle Ryanodine Receptor: A Comparative Molecular Field Analysis. Biochemistry. 33(20). 6074–6085. 37 indexed citations
4.
Bowling, Nancy, Dale E. Mais, Koert Gerzon, & August M. Watanabe. (1994). Ryanodine and an iodinated analog: doxorubicin effects on binding and Ca2+ accumulation in cardiac sarcoplasmic reticulum. European Journal of Pharmacology Molecular Pharmacology. 268(3). 365–373. 7 indexed citations
5.
Bidasee, Keshore R., et al.. (1994). C10‐Oe‐N‐(4‐azido‐5‐125iodo salicyloyl)‐β‐alanyl‐β alanyl ryanodine (Az‐βAR), a novel photo‐affinity ligand for the ryanodine binding site. Journal of Labelled Compounds and Radiopharmaceuticals. 34(1). 33–47. 8 indexed citations
7.
Gerzon, Koert, Rod Humerickhouse, Henry R. Besch, et al.. (1993). Amino- and guanidinoacylryanodines: basic ryanodine esters with enhanced affinity for the sarcoplasmic reticulum calcium (2+)-release channel. Journal of Medicinal Chemistry. 36(10). 1319–1323. 16 indexed citations
8.
Blickenstaff, Robert T., et al.. (1986). Conjugates of steroids and anti-cancer agents. III. The synthesis of estrynamine and certain derivatives. Steroids. 48(3-4). 223–231. 1 indexed citations
9.
Conrad, R., George J. Cullinan, Koert Gerzon, & Gerald A. Poore. (1979). Structure-activity relationships of dimeric Catharanthus alkaloids. 2. Experimental antitumor activities of N-substituted deacetylvinblastine amide (vindesine) sulfates. Journal of Medicinal Chemistry. 22(4). 391–400. 47 indexed citations
10.
Sweeney, Martin, George B. Boder, George J. Cullinan, et al.. (1978). Antitumor activity of deacetyl vinblastine amide sulfate (vindesine) in rodents and mitotic accumulation studies in culture.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(9). 2886–91. 26 indexed citations
11.
Gerzon, Koert, et al.. (1970). Erythromycylamine. Tetrahedron Letters. 11(2). 157–160. 25 indexed citations
12.
Cline, J. C., et al.. (1969). In Vitro Antiviral Activity of Mycophenolic Acid and Its Reversal by Guanine-Type Compounds. Applied Microbiology. 18(1). 14–20. 49 indexed citations
13.
Rh, Williams, et al.. (1968). Fermentation, isolation, and biological properties of mycophenolic acid.. PubMed. 8. 229–33. 7 indexed citations
14.
Zderic, John A., et al.. (1965). Perchloric Acid in the Preparation of 2',3'-Isopropylidene 6-Thioinosine. Journal of Medicinal Chemistry. 8(2). 275–275. 10 indexed citations
15.
Gerzon, Koert, et al.. (1963). The Adamantyl Group in Medicinal Agents. I. Hypoglycemic N-Arylsulfonyl-N'-adamantylureas. Journal of Medicinal Chemistry. 6(6). 760–763. 104 indexed citations
16.
Gerzon, Koert, et al.. (1959). Structure-Activity Relationship of Some Diamine Bis-epoxides in Mouse Leukaemia. Journal of Medicinal Chemistry. 1(3). 223–243. 17 indexed citations
17.
Gerzon, Koert, et al.. (1957). Gibberellenic acid, a by-product of gibberellic acid fermentation. Cellular and Molecular Life Sciences. 13(12). 487–489. 14 indexed citations
18.
Gerzon, Koert, et al.. (1956). Erythromycin. VIII. Structure of Dihydroerythronolide1. Journal of the American Chemical Society. 78(24). 6396–6408. 35 indexed citations
19.
Sigal, Max V., et al.. (1956). Erythromycin. VI. Degradation Studies1. Journal of the American Chemical Society. 78(2). 388–395. 29 indexed citations
20.
Wiley, Paul F., et al.. (1955). ERYTHROMYCIN. IV. DEGRADATIVE STUDIES. Journal of the American Chemical Society. 77(13). 3676–3677. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026